Hashem O. Alsaab
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- RNA Interference and Gene Delivery 6
-
- Nanoplatforms for cancer theranostics 11
- Graphene and Nanomaterials Applications 7
- Co-authors
- Arun K. Iyer (24 shared papers)Samaresh Sau (22 shared papers)Rami M. Alzhrani (18 shared papers)Ketki Bhise (10 shared papers)Sushil K. Kashaw (5 shared papers)Katyayani Tatiparti (5 shared papers)Prashant Kesharwani (5 shared papers)Umesh Gupta (2 shared papers)
- Journals
- Scientific Reports (10 papers)Drug Discovery Today (5 papers)Cancer Research (3 papers)Molecules (3 papers)RSC Advances (3 papers)
- Partner nations
- Saudi ArabiaUnited StatesEgypt
In The Last Decade
Hashem O. Alsaab
106 papers receiving 4.1k citations
Hashem O. Alsaab's Hit Papers
Peers
Comparison fields: 5 of 159
- Biomaterials 605
- Oncology 1.1k
- Immunology 707
- Molecular Medicine 130
- Pharmaceutical Science 157
Countries citing papers authored by Hashem O. Alsaab
This map shows the geographic impact of Hashem O. Alsaab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hashem O. Alsaab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hashem O. Alsaab more than expected).
Fields of papers citing papers by Hashem O. Alsaab
This network shows the impact of papers produced by Hashem O. Alsaab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hashem O. Alsaab. The network helps show where Hashem O. Alsaab may publish in the future.
Co-authors
The 25 scholars most cited alongside Hashem O. Alsaab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome Hit paper breakdown → | 2017 | 1314 |
| 2 | 2020 | 189 | |
| 3 | 2016 | 174 | |
| 4 | 2022 | 167 | |
| 5 | 2016 | 155 | |
| 6 | 2017 | 137 | |
| 7 | 2018 | 125 | |
| 8 | 2020 | 106 | |
| 9 | 2017 | 87 | |
| 10 | 2018 | 66 | |
| 11 | 2021 | 59 | |
| 12 | 2021 | 56 | |
| 13 | 2018 | 53 | |
| 14 | 2019 | 47 | |
| 15 | 2017 | 47 | |
| 16 | 2022 | 46 | |
| 17 | 2022 | 46 | |
| 18 | 2019 | 45 | |
| 19 | 2023 | 43 | |
| 20 | 2018 | 42 |
About Hashem O. Alsaab
Hashem O. Alsaab is a scholar working on Molecular Biology, Biomedical Engineering, Cancer Research, Materials Chemistry and Biomaterials, having authored 113 papers that have together received 4.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (11 papers), Advanced Photocatalysis Techniques (10 papers), Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Graphene and Nanomaterials Applications (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Biomaterials (605 citations), Oncology (1.1k citations), Immunology (707 citations), Molecular Medicine (130 citations) and Pharmaceutical Science (157 citations). Hashem O. Alsaab has collaborated with scholars based in Saudi Arabia, United States and Egypt. Frequent co-authors include Arun K. Iyer, Samaresh Sau, Rami M. Alzhrani, Ketki Bhise, Sushil K. Kashaw, Katyayani Tatiparti, Prashant Kesharwani, Umesh Gupta, Yusuf S. Althobaiti and Hala A. Ibrahium. Their work appears in journals such as Scientific Reports, Drug Discovery Today, Cancer Research, Molecules and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.